<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-JOWZRV4O/a5faba0b-2f63-403f-ac03-558130bde710/PDF"><dcterms:extent>732 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-JOWZRV4O/f5ee2d92-f07d-4f1b-9c4a-b11461ded0ed/TEXT"><dcterms:extent>0 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-JOWZRV4O"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S" /><dcterms:issued>2023</dcterms:issued><dc:creator>Battista, Michela</dc:creator><dc:creator>Bertino, Giulia</dc:creator><dc:creator>Campana, Luca Giovanni</dc:creator><dc:creator>Čemažar, Maja</dc:creator><dc:creator>De Terlizzi, Francesca</dc:creator><dc:creator>Grošelj, Aleš</dc:creator><dc:creator>Kis, Erika</dc:creator><dc:creator>Krt, Aljoša</dc:creator><dc:creator>McCafferty, Ian</dc:creator><dc:creator>Muir, Tobian</dc:creator><dc:creator>Odili, Joy</dc:creator><dc:creator>Omerzel, Maša</dc:creator><dc:creator>Ratnam, Lakshmi</dc:creator><dc:creator>Serša, Gregor</dc:creator><dc:creator>Wohlgemuth, Walter A</dc:creator><dc:creator>Zanasi, Alessandro</dc:creator><dc:format xml:lang="sl">številka:2</dc:format><dc:format xml:lang="sl">letnik:57</dc:format><dc:format xml:lang="sl">str. 141-149</dc:format><dc:identifier>DOI:10.2478/raon-2023-0029</dc:identifier><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>COBISSID:159007235</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-JOWZRV4O</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Croatian Medical Association - Croatian Society of Radiology</dc:publisher><dc:publisher xml:lang="sl">Slovenian Medical Society - Section of Radiology</dc:publisher><dcterms:isPartOf xml:lang="sl">Radiology and oncology (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="sl">bleomycin</dc:subject><dc:subject xml:lang="en">electrosclerotherapy</dc:subject><dc:subject xml:lang="sl">elektroskleroterapija</dc:subject><dc:subject xml:lang="en">vascular malformations</dc:subject><dc:subject xml:lang="sl">žilne malformacije</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations| an International Network for Sharing Practices on Electrochemotherapy (InspECT) study group report|</dc:title><dc:description xml:lang="sl">Biomedical applications of electroporation are expanding out of the field of oncology into vaccination, treatment of arrhythmias and now in the treatment of vascular malformations. Bleomycin is a widely used sclerosing agent in the treatment of various vascular malformations. The application of electric pulses in addition to bleomycin enhances the effectiveness of the drug, as demonstrated by electrochemotherapy, which utilizes bleomycin in the treatment of tumors. The same principle is used in bleomycin electrosclerotherapy (BEST). The approach seems to be effective in the treatment of low-flow (venous and lymphatic) and, potentially, even high-flow (arteriovenous) malformations. Although there are only a few published reports to date, the surgical community is interested, and an increasing number of centers are applying BEST in the treatment of vascular malformations. Within the International Network for Sharing Practices on Electrochemotherapy (InspECT) consortium, a dedicated working group has been constituted to develop standard operating procedures for BEST and foster clinical trials. By treatment standardization and successful completion of clinical trials demonstrating the effectiveness and safety of the approach, higher quality data and better clinical outcomes may be achieved</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-JOWZRV4O"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-JOWZRV4O" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-JOWZRV4O/a5faba0b-2f63-403f-ac03-558130bde710/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo radiologije in onkologije</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-JOWZRV4O/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-JOWZRV4O" /></ore:Aggregation></rdf:RDF>